Navigation Links
Patent for Seminal RNAi innovation Cleared in Australia

Opposition in Australia to the grant of patent application to the Carnegie Institution of Washington in relation to the discovery of RNAi has been withdrawn.// This was announced by the Carnegie Institution of Washington and the University of Massachusetts Medical School. The opposition was originally filed by Benitec, an Australian biotechnogy company, in November 2004. Announcement of the withdrawal will be published in Australia's Official Journal of Patents on August 3, 2006.

Gary Kowalczyk, Carnegie's director of administration and finance, remarked: "The work by Drs. Mello, Fire, and others is widely recognized as the seminal intellectual property in the field of RNAi, and we are pleased that the process of granting a patent in Australia will now move forward. We look forward to companies in Australia licensing this intellectual property, and anticipate similar developments in other countries in the future."

The patent, known popularly as the Fire and Mello patent, was first granted in the United States by the United States Patent and Trademark Office in 2003. Additional patent rights in the United States and elsewhere are pending. To date, the Carnegie Institution, acting upon behalf of itself and the University of Massachusetts Medical School under an interinstitutional agreement, has granted approximately 50 non-exclusive licenses to companies using this invention.

The patent covers a process by which ribonucleic acid (RNA), the cellular material responsible for the transmission of genetic information, can silence a targeted gene within a living cell. The process, called RNA interference (RNAi), can shut down disease-causing genes or direct researchers to pathways for effective drug development.

Source Eurekalert
'"/>




Page: 1

Related medicine news :

1. Indian Government Keen On JE Vaccine Supply And Patenting Of Indian Medicine Formulations
2. HIV Patients Opposes Patenting Of AIDS Drug
3. Provigil Patent Extension Accorded To Cephalon
4. AIDS Sufferers Protest against Proposed Patent for Tenofovir
5. POLY Medicure Ltd Applies for 8 Patents, 2 FDA Approvals
6. Venus Remedies Files 5th International Patent Application
7. US Court Rules Against Lupin in Ramipril Patent Case
8. Canada: On Popular Demand, Tamiflu finds a Berth in the Directory of Patent Drugs
9. Compellis Pharmaceuticals Gets Patent for Obesity-Fighting Nasal Spray CP404
10. A Patented Device for Rapid Diagnosis of Diseases
11. Drop Patent Petition, Activists Ask Novartis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... ... 2017 , ... EpiGentek , a Farmingdale, NY-based biotech ... methylation “gold rush” with their established portfolio of optimized assay kits that measure ... m6A , RNA methylation has received a new burst in interest as ...
(Date:3/27/2017)... ... March 27, 2017 , ... The Anaheim Hills office accelerates ... National Capital has added 10 new sales professionals over the past 6 months and ... 15 additional new hires over the course of 2017. , “This new office ...
(Date:3/27/2017)... ... March 27, 2017 , ... From 1999 to ... responsible for over 33,000 of the 52,404 drug-related deaths in 2015.(2) To combat ... which proposes a tax on prescription opioids to fund drug rehabilitation and prevention ...
(Date:3/25/2017)... ... March 25, 2017 , ... Norland at Swissray is pleased to announce ... large subjects. The ELITE DXA has an active scan window, which is more than ... to fit in the scan area could not undergo an accurate total body bone density ...
(Date:3/24/2017)... , ... March 24, 2017 , ... Digital Scientists, a ... to announce the opening of a Greenville, South Carolina location. The lab ... progress in Greenville. , “We’ve been working with South Carolina clients for years from ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... SAN DIEGO and VANCOUVER, British Columbia, March 27, ... SPHS ) (the "Company" or "Sophiris"), a clinical ... treatment of patients with urological diseases, today reported ... and key corporate highlights. Key ... in Clinical Development for Localized Prostate Cancer. During ...
(Date:3/27/2017)... FinancialBuzz.com News Commentary  ... According to a new report by Arcview Market Research, the legal cannabis ... to $6.7 billion and can be expected to grow at a 27 ... from $6.7 billion in 2016, to $22.6 billion in 2021. This more ... cannabis without a doctor,s recommendation. Voters in California , ...
(Date:3/27/2017)... /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus MD" or ... is pleased to announce it has received conditional approval ... TSX Venture Exchange.  Receiving the conditional ... significant achievements for Invictus-MD. Some of which include: ... Laboratories Inc. ("AB Labs"), a Licensed Producer under the ...
Breaking Medicine Technology: